Related Experiment Video
Updated: Dec 25, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Clinical Case
Adelaide Pereira Alves1, Ana Barroso1, Margarida Dias1
1Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare lung condition. Early diagnosis and management are crucial as DIPNECH is a pre-invasive lesion for lung carcinoid tumors.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) involves abnormal growth of neuroendocrine cells in the airways.
- This rare condition can be challenging to diagnose, potentially delaying treatment.
- DIPNECH is recognized as a pre-neoplastic lesion for lung carcinoid tumors.
Purpose of the Study:
- To present a clinical case of DIPNECH.
- To discuss the diagnostic and therapeutic strategies for DIPNECH.
- To highlight the need for established management guidelines for this condition.
Main Methods:
- Case report presentation.
- Review of diagnostic modalities for DIPNECH.
- Discussion of therapeutic options based on clinical presentation.
Main Results:
- DIPNECH presents with diffuse neuroendocrine cell proliferation in the bronchial epithelium.
- Clinical manifestations include obstructive respiratory symptoms.
- Radiological findings may show small airway disease and pulmonary nodules.
Conclusions:
- DIPNECH is an under-recognized pulmonary condition with potential progression to neuroendocrine tumors.
- Diagnosis requires a high index of suspicion due to subtle clinical and radiological signs.
- Treatment is symptom-driven, and prognosis varies significantly.
More Related Videos
06:03Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
Published on: May 23, 2015
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024